LAVA Therapeutics Statistics
Total Valuation
LVTX has a market cap or net worth of $45.77 million. The enterprise value is -$3.89 million.
| Market Cap | 45.77M |
| Enterprise Value | -3.89M |
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LVTX has 26.31 million shares outstanding. The number of shares has decreased by -0.86% in one year.
| Current Share Class | 26.31M |
| Shares Outstanding | 26.31M |
| Shares Change (YoY) | -0.86% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 11.30% |
| Float | 17.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.38 |
| Forward PS | n/a |
| PB Ratio | 3.61 |
| P/TBV Ratio | 3.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.27
| Current Ratio | 12.27 |
| Quick Ratio | 11.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -84.85 |
Financial Efficiency
Return on equity (ROE) is -101.51% and return on invested capital (ROIC) is -51.84%.
| Return on Equity (ROE) | -101.51% |
| Return on Assets (ROA) | -19.92% |
| Return on Invested Capital (ROIC) | -51.84% |
| Return on Capital Employed (ROCE) | -45.20% |
| Revenue Per Employee | $146,765 |
| Profits Per Employee | -$681,853 |
| Employee Count | 34 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LVTX has paid $683,000 in taxes.
| Income Tax | 683,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.90% in the last 52 weeks. The beta is 0.50, so LVTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +11.90% |
| 50-Day Moving Average | 1.59 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 62.23 |
| Average Volume (20 Days) | 131,805 |
Short Selling Information
The latest short interest is 425,851, so 1.62% of the outstanding shares have been sold short.
| Short Interest | 425,851 |
| Short Previous Month | 179,838 |
| Short % of Shares Out | 1.62% |
| Short % of Float | 2.42% |
| Short Ratio (days to cover) | 0.88 |
Income Statement
In the last 12 months, LVTX had revenue of $4.99 million and -$23.18 million in losses. Loss per share was -$0.86.
| Revenue | 4.99M |
| Gross Profit | 4.99M |
| Operating Income | -21.55M |
| Pretax Income | -22.50M |
| Net Income | -23.18M |
| EBITDA | -21.33M |
| EBIT | -21.55M |
| Loss Per Share | -$0.86 |
Balance Sheet
The company has $49.66 million in cash and n/a in debt, giving a net cash position of $49.66 million or $1.89 per share.
| Cash & Cash Equivalents | 49.66M |
| Total Debt | n/a |
| Net Cash | 49.66M |
| Net Cash Per Share | $1.89 |
| Equity (Book Value) | 12.68M |
| Book Value Per Share | 0.48 |
| Working Capital | 47.67M |
Cash Flow
| Operating Cash Flow | -30.76M |
| Capital Expenditures | n/a |
| Free Cash Flow | -30.76M |
| FCF Per Share | -$1.17 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -431.92% |
| Pretax Margin | -450.90% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.86% |
| Shareholder Yield | 0.86% |
| Earnings Yield | -50.65% |
| FCF Yield | -67.20% |
Analyst Forecast
The average price target for LVTX is $1.58, which is -9.20% lower than the current price. The consensus rating is "Hold".
| Price Target | $1.58 |
| Price Target Difference | -9.20% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -22.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LVTX has an Altman Z-Score of -4.86 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.86 |
| Piotroski F-Score | 2 |